top of page

Congratulations to Amryt Pharma - recipients of a EURORDIS Black Pearl Award!

Updated: Feb 28, 2023

Amryt Pharma received the EURORDIS company award for patient engagement at the Black Pearl Awards on 21 February 2023.

We are delighted to share the news of Amryt Pharma were awarded the EURORDIS Company Award for Patient Engagement for their commitment to serving and empowering rare disease patients through meaningful collaboration.

Amryt Pharma has been a long-standing supporter, and more importantly, consistent and transparent communicator with DEBRA groups worldwide. We are delighted that their patient-centred approach to their work has helped lead to the first approved treatment for EB in the EU and UK.

The formation of a natural black pearl is extremely rare – as are the individuals, organisations and companies who dedicate their lives to making a difference for the rare disease community. The EURORDIS Black Pearl Awards recognises and honours with admiration the dedication of those who contribute to improving lives and finding cures for people living with a rare disease.

Congratulations once again!

24 views0 comments


bottom of page